FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Newell William E

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/5/2018 

3. Issuer Name and Ticker or Trading Symbol

DENTSPLY SIRONA Inc. [XRAY]

(Last)        (First)        (Middle)

221 W PHILADELPHIA ST, STE 60W

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP Consumables Endo Ortho /

(Street)

YORK, PA 17401       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   9093.426   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP     (1)   (1) Common Stock   8871.144     (1) D    
Stock Option (Right to Buy)     (2) 12/8/2018   Common Stock   12150   $25.91   D    
Stock Option (Right to Buy)     (2) 12/8/2019   Common Stock   11400   $33.86   D    
Stock Option (Right to Buy)     (2) 2/11/2021   Common Stock   10800   $36.62   D    
Stock Option (Right to Buy)     (2) 2/21/2022   Common Stock   19000   $38.74   D    
Stock Option (Right to Buy)     (2) 2/25/2023   Common Stock   13800   $40.86   D    
Stock Option (Right to Buy)     (2) 2/24/2024   Common Stock   14500   $45.11   D    
Stock Option (Right to Buy)     (2) 2/23/2025   Common Stock   13500   $52.00   D    
Stock Option (Right to Buy)     (3) 2/17/2026   Common Stock   10400   $55.91   D    
Stock Option (Right to Buy)     (4) 2/22/2027   Common Stock   9900   $62.34   D    
Stock Option (Right to Buy)     (5) 8/11/2027   Common Stock   1500   $55.33   D    

Explanation of Responses:
(1)  The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
(2)  This option is fully vested and exercisable.
(3)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 17, 2019.
(4)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending February 22, 2020.
(5)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending August 11, 2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Newell William E
221 W PHILADELPHIA ST, STE 60W
YORK, PA 17401


SVP Consumables Endo Ortho

Signatures
Dane Baumgardner, Attorney-In-Fact for William E Newell 3/15/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more DENTSPLY SIRONA Charts.